<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H365A0F036F4045ADADC0D8A447AE826D" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 10359 IH: Priority for Pediatric Cures Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2026-09-14</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 10359</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20260914">September 14, 2026</action-date><action-desc><sponsor name-id="B001257">Mr. Bilirakis</sponsor> (for himself, <cosponsor name-id="B001300">Ms. Barragán</cosponsor>, <cosponsor name-id="C001039">Mrs. Cammack</cosponsor>, <cosponsor name-id="A000148">Mr. Auchincloss</cosponsor>, <cosponsor name-id="K000398">Mr. Kean</cosponsor>, and <cosponsor name-id="M001225">Mr. Mullin</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.</official-title></form><legis-body id="HA7C52CADDCE7436DA695717276A8752A" style="OLC"> 
<section id="HDE17FC02C00B477ABE4ECD865591D766" section-type="section-one"><enum>1.</enum><header>Short title</header>
 <text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Priority for Pediatric Cures Act</short-title></quote>.</text> </section> 
<section id="H083289421AA34D7EAFE8DF078467B91F" section-type="subsequent-section"><enum>2.</enum><header>Permanent extension of authority to award priority review vouchers for rare pediatric disease products</header><text display-inline="no-display-inline">Section 529(b) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360ff">21 U.S.C. 360ff(b)</external-xref>) is amended by striking paragraph (5).</text></section> </legis-body></bill>

